Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanhe Wang

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Cancer Letters|March 22, 2017
An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-κBTian-Shu Kang, Wanhe Wang, Hai-Jing Zhong, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 12, 2025
A Bivalent Iridium(III) Complex Toolkit for Mitochondrial DNA G-Quadruplex-Targeted TheranosticsYiwen Xu, Ling Wang, Jianxiong Du, et al.
Chemical Science|September 30, 2017
Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts <i>in vivo</i> by an enantiomeric iridium(iii) metal-based compoundLi-Juan Liu, Wanhe Wang, Shi-Ying Huang, et al.
Redox Biology|September 16, 2021
A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1-Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injuryGuodong Li, Hao Liu, Ruibing Feng, et al.
Experimental & Molecular Medicine|July 20, 2022
Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9Guodong Li, Dan Li, Chun Wu, et al.
Oncotarget|February 18, 2016
Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compoundsLi-Juan Liu, Bingyong He, Jennifer A Miles, et al.
Nature Communications|June 8, 2021
A small molecule HIF-1α stabilizer that accelerates diabetic wound healingGuodong Li, Chung-Nga Ko, Dan Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 19, 2025
A Bioactive Benzimidazole-Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED-EZH2 InteractionShasha Cheng, Jian Li, Ying-Qi Song, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancerSha-Sha Cheng, Yuan-Qing Qu, Jia Wu, et al.
Journal of the American Chemical Society|April 19, 2025
Inhibiting Glycolysis and Disrupting the Mitochondrial HK2-VDAC1 Protein-Protein Interaction Using a Bifunctional Lonidamine-Conjugated Metal Probe for Combating Triple-Negative Breast CancerLing Wang, Lingtan Kong, Ding-Qi Zhang, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cancer Letters|March 22, 2017
An anti-prostate cancer benzofuran-conjugated iridium(III) complex as a dual inhibitor of STAT3 and NF-κBTian-Shu Kang, Wanhe Wang, Hai-Jing Zhong, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 12, 2025
A Bivalent Iridium(III) Complex Toolkit for Mitochondrial DNA G-Quadruplex-Targeted TheranosticsYiwen Xu, Ling Wang, Jianxiong Du, et al.
Chemical Science|September 30, 2017
Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts <i>in vivo</i> by an enantiomeric iridium(iii) metal-based compoundLi-Juan Liu, Wanhe Wang, Shi-Ying Huang, et al.
Redox Biology|September 16, 2021
A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1-Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injuryGuodong Li, Hao Liu, Ruibing Feng, et al.
Experimental & Molecular Medicine|July 20, 2022
Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9Guodong Li, Dan Li, Chun Wu, et al.
Oncotarget|February 18, 2016
Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compoundsLi-Juan Liu, Bingyong He, Jennifer A Miles, et al.
Nature Communications|June 8, 2021
A small molecule HIF-1α stabilizer that accelerates diabetic wound healingGuodong Li, Chung-Nga Ko, Dan Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 19, 2025
A Bioactive Benzimidazole-Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED-EZH2 InteractionShasha Cheng, Jian Li, Ying-Qi Song, et al.
Acta Pharmaceutica Sinica. B|May 9, 2022
Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancerSha-Sha Cheng, Yuan-Qing Qu, Jia Wu, et al.
Journal of the American Chemical Society|April 19, 2025
Inhibiting Glycolysis and Disrupting the Mitochondrial HK2-VDAC1 Protein-Protein Interaction Using a Bifunctional Lonidamine-Conjugated Metal Probe for Combating Triple-Negative Breast CancerLing Wang, Lingtan Kong, Ding-Qi Zhang, et al.
Pageof 10